ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 124,000 shares, a decrease of 6.3% from the January 15th total of 132,400 shares. Based on an average daily volume of 2,470,000 shares, […]
FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agreement to license certain of its healthcare-related expertise ("Know-How") to Senior Paradise, Inc. ("SPI"), who will also lease certain of the Company's properties (the "Land") for further development relat
Shares of BATM Advanced Communications Ltd. (LON:BVC – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 24.99 ($0.31) and traded as low as GBX 20.15 ($0.25). BATM Advanced Communications shares last traded at GBX 20.48 ($0.26), […]
By Chris Wack ABVC BioPharma shares were up 11% to $1.87 after the received a U.S. patent for the use of PDC-1421, which is used in the company's asset.